MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)
Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –
MeiraGTx gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for MeiraGTx
MeiraGTx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?